Trials / Completed
CompletedNCT00316654
Persistence of Antibody Response to N. Meningitidis Group C in Children
A Phase IV,Multi-Center,Open-Label,Unrandomized Study to Evaluate the Persistence of Antibody Response to N.Meningitidis Group C,Before & After 2 Doses of the Conjugate Pneumococcal Vaccine,in Children Seven Months & Older Who Previously Received Immunization With Chiron Meningococcal C Conjugate Vaccine & a Hexavalent Infant Vaccine According to the Applicable Infant Immunization Schedule
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 489 (actual)
- Sponsor
- Novartis Vaccines · Industry
- Sex
- All
- Age
- 7 Months
- Healthy volunteers
- Accepted
Summary
Persistence of Antibody Response to N. meningitidis Group C in Children
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Meningococcal C conjugate vaccine |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2005-10-01
- Completion
- 2005-10-01
- First posted
- 2006-04-21
- Last updated
- 2017-07-25
Locations
2 sites across 2 countries: Poland, Spain
Source: ClinicalTrials.gov record NCT00316654. Inclusion in this directory is not an endorsement.